As a leader in the eye care industry, Shenyang Xingqi Pharmaceutical Co., Ltd. (hereinafter referred to as “Xingqi”) has invested heavily in equipment for product R & D and quality control. To further increase the accuracy in testing, the company has recently implemented an overall upgrade of the autonomous microbial gene fingerprint identification system workstation of its quality inspection center.